midostaurin: the first drug to receive approval for aml since 2000
Published 6 years ago • 242 plays • Length 2:28Download video MP4
Download video MP3
Similar videos
-
1:21
gemtuzumab-based induction chemotherapy with midostaurin in flt3-mutated aml
-
2:12
midostaurin for newly diagnosed flt3 aml: radius-x efficacy and safety data
-
2:08
comparing midostaurin to next-generation flt3 inhibitors in the frontline treatment of flt3-itd aml
-
0:59
midostaurin: a step forward in the treatment of flt3-mutated aml
-
3:12
go plus midostaurin and intensive chemotherapy in cbf and flt-mut aml
-
3:42
midostaurin in c-kit or flt3-itd mutated t(8;21) aml
-
2:40
what we still don't know about the ratify study of midostaurin in aml
-
1:36
midostaurin and quizartinib: improving survival and day-to-day life in aml
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
7:46
updates in aml treatment and research from asco 2023
-
1:25
exciting updates in essential thrombocythemia: exploring novel agents
-
3:31
update on quantum-first: quizartinib soc chemotherapy & as continuation therapy in flt3-itd aml
-
1:28
flt3 inhibitors for treating aml
-
1:34
v-fast subgroup analysis: cpx-351 plus midostaurin for newly diagnosed flt3-mutated aml
-
1:32
integrating midostaurin into flt3 positive aml treatment
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
1:58
efficacy of first generation flt3 inhibitors for aml
-
3:56
radius results: midostaurin reduces relapse after asct in flt3-itd aml
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
0:48
an introduction to the maxilus study: the optimal dose of luspatercept in lr-mds
-
1:03
an insight into the sequencing of immunotherapies in adults with all
-
1:56
promising targets beyond flt3 in aml: idh1/2 & menin